Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2009
Business Overview: ASHS provides medical equipment and services, primarily Gamma Knife radiosurgery units to 19 medical centers, and radiation therapy equipment (IMRT, IGRT). The company also holds a 3.7% investment in Still River Systems, Inc., a developer of proton beam radiation therapy systems.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Medical Services Revenue | $4,167,000 | $4,725,000 |
| Gross Margin | $1,597,000 (38.3%) | $2,069,000 (43.8%) |
| Operating Income (Loss) | $(76,000) | $394,000 |
| Net Income (Loss) Attributable to ASHS | $(94,000) | $156,000 |
| Diluted EPS | $(0.02) | $0.03 |
| Cash and Cash Equivalents | $9,546,000 | $6,292,000 |
| Total Debt (Current + Long-term) | $21,219,000 | N/A |
| Working Capital | $(769,000) Deficit | N/A |
Note: Total Debt calculated as Current portion of long-term debt ($6.085M) + Current capital leases ($1.192M) + Line of credit ($6.9M) + Long-term debt ($15.134M) + Long-term capital leases ($4.372M).
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by $558,000 (11.8%) primarily due to low volume at one Gamma Knife site and extended downtime for a Perfexion unit upgrade. Procedures dropped from 477 to 431.
- Profitability Shift: The company moved from an operating income of $394,000 in Q1 2008 to an operating loss of $76,000 in Q1 2009. This was driven by revenue declines and $197,000 in transaction costs related to potential asset sales.
- Cost Management: Total costs of revenue decreased by $86,000 due to lower site-specific marketing and operating costs, partially offset by increased maintenance and depreciation from equipment upgrades.
- Interest Expense: Decreased by $85,000 due to lower line of credit interest, partially offset by new financing for equipment upgrades.
Guidance, Outlook, and Risks
- Asset Sale Discussions: The company is in preliminary negotiations to sell its 81% interest in GK Financing (GKF). Transaction costs of $197,000 were expensed in Q1 2009. No agreement is guaranteed.
- Investment Impairment: ASHS holds a $2.617 million investment in Still River Systems. While an unrealized loss of approximately $1.2 million exists based on recent financing rounds, management deems the impairment temporary due to Still River's successful prototype testing and ability to raise capital.
- Capital Commitments: The company has approximately $41 million in remaining commitments to purchase equipment, including three Monarch250 proton beam systems (delivery anticipated in 2010) and Gamma Knife upgrades. Management intends to finance these as needed.
- Liquidity: Despite a working capital deficit of $769,000, management believes cash flow from operations and an $8 million line of credit (with $6.9 million currently drawn) are sufficient to meet obligations for the next 12 months.
- Stock Repurchase: The company repurchased 21,245 shares in Q1 2009 at an average price of $2.13. Approximately 178,501 shares remain available under the current authorization.
Investor Verification Checklist
- Transaction Costs: Verify the status of the potential sale of the 81% interest in GK Financing and the likelihood of closing.
- Still River Investment: Monitor the development of the PBRT system and the risk of the $2.6 million investment becoming "other-than-temporarily" impaired if FDA approval is delayed or financing fails.
- Equipment Downtime: Assess the impact of the Perfexion unit upgrade on future revenue recovery and the timeline for full operational capacity.
- Debt Covenants: Review the terms of the $8 million line of credit and long-term debt to ensure compliance given the working capital deficit.
- Capital Expenditures: Confirm the financing strategy for the $41 million in equipment purchase commitments, particularly the unproven Monarch250 systems.